APA (7th ed.) Citation

A, H., T, N., JS, V., K, M., A, M., P, E., & SS, P. (2024). Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration. Clinical ophthalmology (Auckland, N.Z.), 18, 3781. https://doi.org/10.2147/OPTH.S494605

Chicago Style (17th ed.) Citation

A, Hang, Ngo T, Virk JS, Moussa K, Moshiri A, Emami-Naeini P, and Park SS. "Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration." Clinical Ophthalmology (Auckland, N.Z.) 18 (2024): 3781. https://doi.org/10.2147/OPTH.S494605.

MLA (9th ed.) Citation

A, Hang, et al. "Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration." Clinical Ophthalmology (Auckland, N.Z.), vol. 18, 2024, p. 3781, https://doi.org/10.2147/OPTH.S494605.